Development of Assist Tool for Breast Examination Using the Principle of Ultrasonic Sensor
1 other identifier
observational
200
1 country
1
Brief Summary
The accuracy of breast examinations and ultrasonography performed clinically to detect breast mass varies greatly depending on the physician\'s skill level, and the accuracy of breast examinations by non-experts is particularly low. In this study, we aimed to validate whether the concurrent use of ultrasound sensor technology is an efficient strategy for the purpose of improving the sensitivity of detecting breast masses through breast examination.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Oct 2024
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 4, 2024
CompletedFirst Posted
Study publicly available on registry
February 13, 2024
CompletedStudy Start
First participant enrolled
October 5, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 27, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
April 5, 2025
CompletedDecember 4, 2024
December 1, 2024
5 months
February 4, 2024
December 3, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Device performance
Sensitivity/specificity/predictive value/accuracy/positive predictive value/ negative predictive value of diagnostic performance
Within 1 year after the study participant registration deadline
Secondary Outcomes (1)
Artificial intelligence algorithm efficacy
Within 2 year after the study participant registration deadline
Study Arms (1)
Ultrasonic group
Eligibility Criteria
scheduled for surgery after a tumor has been confirmed on breast ultrasound examination
You may qualify if:
- female patients between 18 and 80 years of age who are scheduled for surgery after a tumor has been confirmed on breast ultrasound examination
You may not qualify if:
- Patients diagnosed with breast cancer after biopsy with non-mass enhancement or calcification
- Inflammatory breast cancer
- Patients whose cancer has invaded the skin and broken through
- Patients with skin diseases
- Women who refused to participate in the study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Seoul National University Hospital
Seoul, 03080, South Korea
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professior
Study Record Dates
First Submitted
February 4, 2024
First Posted
February 13, 2024
Study Start
October 5, 2024
Primary Completion
February 27, 2025
Study Completion
April 5, 2025
Last Updated
December 4, 2024
Record last verified: 2024-12
Data Sharing
- IPD Sharing
- Will not share